Mertect 160
Brand names,
Mertect 160
Analogs
Mertect 160
Brand Names Mixture
Mertect 160
Chemical_Formula
C11H16N2O
Mertect 160
RX_link
http://www.rxlist.com/cgi/generic3/tocainide.htm
Mertect 160
fda sheet
Mertect 160
msds (material safety sheet)
Mertect 160
Synthesis Reference
No information avaliable
Mertect 160
Molecular Weight
192.258 g/mol
Mertect 160
Melting Point
246-266 oC
Mertect 160
H2O Solubility
1.07E+004 mg/L
Mertect 160
State
Solid
Mertect 160
LogP
1.308
Mertect 160
Dosage Forms
400 mg and 600 mg tablets for oral administration
Mertect 160
Indication
For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening.
Mertect 160
Pharmacology
Tocainide is a primary amine analog of lidocaine with antiarrhythmic properties useful in the treatment of ventricular arrhythmias. Tocainide, like lidocaine, produces dose dependent decreases in sodium and potassium conductance, thereby decreasing the excitability of myocardial cells. In experimental animal models, the dose-related depression of sodium current is more pronounced in ischemic tissue than in normal tissue. Tocainide is a Class I antiarrhythmic compound with electrophysiologic properties in man similar to those of lidocaine, but dissimilar from quinidine, procainamide, and disopyramide.
Mertect 160
Absorption
Following oral administration, the bioavailability approaches 100 percent, and is unaffected by food.
Mertect 160
side effects and Toxicity
The oral LD50 of tocainide was calculated to be about 800 mg/kg in mice, 1000 mg/kg in rats, and 230 mg/kg in guinea pigs; deaths were usually preceded by convulsions.
Mertect 160
Patient Information
Mertect 160
Organisms Affected
Humans and other mammals